Literature DB >> 6400120

Expression at the haemopoietic stem cell level of the genetically determined erythrocyte membrane defects in the Milan hypertensive rat strain (MHS).

D Trizio, P Ferrari, M Ferrandi, L Torielli, G Bianchi.   

Abstract

Both humans and rats with essential or genetic arterial hypertension show many alterations of erythrocyte membrane ion transport. The Milan hypertensive rat strain (MHS) has smaller red cells and faster Na+/K+ cotransport across erythrocyte membrane when compared with the control strain (MNS). In order to distinguish if these alterations are due to some inherited cell membrane characteristics or are secondary to some extrinsic factor responsible for hypertension, we have transplanted bone marrow (BM) cells from MHS or MNS rats to two groups of F1 hybrids, lethally irradiated (850 R). Three months after BM transplantation the F1 recipients were killed and their erythrocytes studied. The differences between erythrocytes of F1 MHS BM recipients and F1 MNS BM recipients follow the same pattern described for the donor parental strains. These results indicate that the MHS red cell abnormalities are present in the haemopoietic stem cell and therefore the MHS erythrocyte defects are not due to some extrinsic factors.

Entities:  

Mesh:

Year:  1983        PMID: 6400120

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  3 in total

Review 1.  Personalized Therapy of Hypertension: the Past and the Future.

Authors:  Paolo Manunta; Mara Ferrandi; Daniele Cusi; Patrizia Ferrari; Jan Staessen; Giuseppe Bianchi
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

2.  Increased renal tubular Na-K-ATPase activity in Milan hypertensive rats in the prehypertensive period.

Authors:  M L Melzi; M L Syrén; B M Assael; F Sereni; A Aperia
Journal:  Pediatr Nephrol       Date:  1991-11       Impact factor: 3.714

Review 3.  Genetic models of arterial hypertension--role of tubular ion transport.

Authors:  D Cusi; M L Melzi; C Barlassina; F Sereni; G Bianchi
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.